In Q1 of the fiscal year ending March 2027, revenue was ¥2,371 million, up 18.0% year on year, while operating profit was ¥280 million, up 119.4%. Progress against the full-year forecast was 23.7% for revenue and 62.2% for operating profit. The H1 results should clarify whether this earnings lead reflects accumulated orders and sales or includes temporary factors such as the timing of project recognition.
All recorded disclosures and news since the latest annual or semiannual filing. Switching watchpoints keeps the full history. Select an item to inspect its source.2026-06-25 〜 2026-10-31 · 6 of 6 items
Scroll the timeline →
Will H1 revenue reach at least ¥5,000 million, or 50.0% of the ¥10,000 million full-year forecast?
Will H1 operating profit exceed ¥225 million, or 50.0% of the ¥450 million full-year forecast?
Will the H1 operating margin remain at the Q1 calculated level of 11.8%, or move closer to the 9.9% achieved in the previous fiscal year?
Will the full-year forecasts of ¥10,000 million in revenue and ¥450 million in operating profit be revised?
Q1 revenue was ¥2,371 million and operating profit was ¥280 million, representing progress of 23.7% and 62.2%, respectively, against the full-year forecasts. Based on a simple calculation using the full-year forecasts, the company would reach its targets by recording ¥7,629 million in revenue and ¥170 million in operating profit over the remaining 9 months. Operating profit has already exceeded half of the full-year plan in Q1 alone, making the first point to confirm whether additional profit in H1 will push operating profit above the full-year forecast.
The Q1 operating margin was approximately 11.8% based on the disclosed revenue and operating profit, about 1.9 percentage points above the 9.9% achieved for the full fiscal year ending March 2026. Operating profit growth of 119.4% substantially exceeded revenue growth of 18.0%, suggesting that factors such as product mix, project profitability, and the burden of costs and SG&A may have contributed in addition to higher revenue. However, no bridge breaking down the increase in profit by price, volume, product mix, and cost factors could be confirmed.
Q1 orders were also ¥4,549 million, up 26.4% year on year, making it important to assess how much of the order intake has accumulated toward H1 sales recognition. At the same time, the order backlog has not been disclosed, so it is not possible to determine how much the ¥4,549 million in orders will support sales and profit from Q2 onward. H1 order intake, order backlog, and recognized revenue should be reviewed together to determine whether the 11.8% margin is temporary or sustainable.
Ordinary profit was ¥292 million, and profit attributable to owners of the parent was ¥199 million, representing progress of 64.9% and 66.3%, respectively, against the full-year forecasts. The key issue is not only whether H1 net profit will exceed ¥150 million, half of the ¥300 million full-year forecast, but also whether the increase in operating profit will continue into the second half. At the next earnings announcement, it will be important to confirm whether the full-year forecasts will be maintained or whether any of revenue, operating profit, and net profit will be revised.
First-quarter progress against full-year forecasts (%)
Select a value or step to inspect its source.
Ordered by date. Disclosures and financial records differ from news and company threads; open each source to inspect it.
2026-11-06 · Awaiting publication
· Awaiting publication
The prior-year comparison for this event
2025-11-07 disclosed · In ¥ millions; each quarter is cumulative from the start of the fiscal year. EPS is in yen.
Latest available: FY2027 Q1
Net salesBusiness scale
3,654JPY m
↘ -9.6% YoYOperating profitCore earnings
86JPY m
↘ -23.2% YoYNewest first. The highlighted column is this event’s comparison. YoY uses the same period and accounting basis.
| Metric | FY2027 Q1 | FY2026 full year | FY2026 Q3 | FY2026 Q2Comparison | FY2026 Q1 | FY2025 full year | FY2025 Q3 | FY2025 Q2 |
|---|---|---|---|---|---|---|---|---|
| Net sales | 2,371↗ +18.0% YoY | 8,638↘ -6.2% YoY | 5,836↘ -6.8% YoY | 3,654↘ -9.6% YoY | 2,010YoY unavailable | 9,212YoY unavailable | 6,262YoY unavailable | 4,044YoY unavailable |
| Operating profit | 280↗ +120.5% YoY | 856↗ +16.5% YoY | 414↗ +72.5% YoY | 86↘ -23.2% YoY | 127YoY unavailable | 735YoY unavailable | 240YoY unavailable | 112YoY unavailable |
| Ordinary profit | 292↗ +117.9% YoY | 871↗ +17.1% YoY | 433↗ +75.3% YoY | 94↘ -15.3% YoY | 134YoY unavailable | 744YoY unavailable | 247YoY unavailable | 111YoY unavailable |
| Net income | 199↗ +109.5% YoY | 648↗ +14.1% YoY | 305↗ +90.6% YoY | 68↘ -9.3% YoY | 95YoY unavailable | 568YoY unavailable | 160YoY unavailable | 75YoY unavailable |
| Earnings per share | 150.95↗ +111.5% YoY | 487.06↗ +16.8% YoY | 228.93↗ +95.6% YoY | 51.54↘ -6.6% YoY | 71.36YoY unavailable | 417.11YoY unavailable | 117.06YoY unavailable | 55.17YoY unavailable |